New drug combo tested for Tough-to-Treat kidney cancer
Disease control
Recruiting now
This study is for people with advanced kidney cancer that has come back after they received standard post-surgery treatment. It aims to see if a new drug called zanzalintinib, taken alone or combined with an immunotherapy drug (nivolumab), can help control the cancer. About 70 pa…
Phase: PHASE2 • Sponsor: Karie Runcie • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC